Prestige Consumer Healthcare Inc (PBH)
70.14
+0.01
(+0.01%)
USD |
NYSE |
Apr 25, 16:00
70.09
-0.05
(-0.07%)
After-Hours: 20:00
Prestige Consumer Healthcare Total Return Price: 70.14 for April 25, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 25, 2024 | 70.14 |
April 24, 2024 | 70.13 |
April 23, 2024 | 71.22 |
April 22, 2024 | 69.80 |
April 19, 2024 | 69.67 |
April 18, 2024 | 68.35 |
April 17, 2024 | 68.03 |
April 16, 2024 | 68.06 |
April 15, 2024 | 68.14 |
April 12, 2024 | 68.23 |
April 11, 2024 | 69.19 |
April 10, 2024 | 68.93 |
April 09, 2024 | 69.18 |
April 08, 2024 | 68.63 |
April 05, 2024 | 69.15 |
April 04, 2024 | 69.78 |
April 03, 2024 | 69.43 |
April 02, 2024 | 69.96 |
April 01, 2024 | 71.68 |
March 28, 2024 | 72.56 |
March 27, 2024 | 72.63 |
March 26, 2024 | 72.00 |
March 25, 2024 | 71.59 |
March 22, 2024 | 73.25 |
March 21, 2024 | 73.89 |
Date | Value |
---|---|
March 20, 2024 | 73.39 |
March 19, 2024 | 73.56 |
March 18, 2024 | 73.63 |
March 15, 2024 | 74.67 |
March 14, 2024 | 74.02 |
March 13, 2024 | 75.07 |
March 12, 2024 | 74.15 |
March 11, 2024 | 74.58 |
March 08, 2024 | 73.70 |
March 07, 2024 | 72.61 |
March 06, 2024 | 71.40 |
March 05, 2024 | 71.24 |
March 04, 2024 | 71.98 |
March 01, 2024 | 70.13 |
February 29, 2024 | 69.58 |
February 28, 2024 | 69.58 |
February 27, 2024 | 69.86 |
February 26, 2024 | 69.98 |
February 23, 2024 | 69.72 |
February 22, 2024 | 69.40 |
February 21, 2024 | 69.29 |
February 20, 2024 | 68.76 |
February 16, 2024 | 69.14 |
February 15, 2024 | 68.78 |
February 14, 2024 | 67.70 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
29.02
Minimum
May 30 2019
75.07
Maximum
Mar 13 2024
50.05
Average
53.32
Median
Apr 07 2022
Total Return Price Benchmarks
NovaBay Pharmaceuticals Inc | 0.077 |
Palatin Technologies Inc | 1.72 |
iBio Inc | 1.72 |
Theriva Biologics Inc | 0.4100 |
Oragenics Inc | 1.06 |